Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | AML: the cytogenetic risk score

Arnon Nagler, MD, MSc, Sheba Medical Center, Tel-Aviv, Israel, discusses the cytogenetic abnormalities seen in acute myeloid leukemia (AML), the development of a cytogenetic risk score and how this is important to allogeneic stem cell transplantation (ASCT). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).